Consortium to Build Quantum-Enabled 'Brain-on-Chip' Platform for Neurological Drug Discovery and Screening
Platform to detect human-relevant insights for discovery and development of therapies for neurological diseases, including Alzheimer's, epilepsy, schizophrenia MELBOURNE, AUSTRALIA, March 3, 2026 /EINPresswire.com/ -- Chromos Labs, Tessara …